Becquemont_1997_Clin.Pharmacol.Ther_61_619

Reference

Title : Influence of the CYP1A2 inhibitor fluvoxamine on tacrine pharmacokinetics in humans - Becquemont_1997_Clin.Pharmacol.Ther_61_619
Author(s) : Becquemont L , Ragueneau I , Le Bot MA , Riche C , Funck-Brentano C , Jaillon P
Ref : Clinical Pharmacology & Therapeutics , 61 :619 , 1997
Abstract : Becquemont_1997_Clin.Pharmacol.Ther_61_619
ESTHER : Becquemont_1997_Clin.Pharmacol.Ther_61_619
PubMedSearch : Becquemont_1997_Clin.Pharmacol.Ther_61_619
PubMedID: 9209244

Related information

Citations formats

Becquemont L, Ragueneau I, Le Bot MA, Riche C, Funck-Brentano C, Jaillon P (1997)
Influence of the CYP1A2 inhibitor fluvoxamine on tacrine pharmacokinetics in humans
Clinical Pharmacology & Therapeutics 61 :619

Becquemont L, Ragueneau I, Le Bot MA, Riche C, Funck-Brentano C, Jaillon P (1997)
Clinical Pharmacology & Therapeutics 61 :619